Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1256 results for "sun pharma"

Biocon, Sun Pharma awarded for innovation

Study shows high tech engineering, pharma as front runners of innovation in India Biocon and Sun Pharma were honoured at Thomson Reuters India Innovation Awards 2014, announced at the recent launch of its 2014 State of Innovation India report. Financial Express, 1 day ago

101 images for sun pharma

Sify, 2 days ago
NDTV Profit, 1 week ago
NDTV Profit, 1 week ago
Oneindia, 1 week ago
Deccan Chronicle, 1 week ago
Business Today India, 1 week ago
Money Today, 1 week ago
NDTV Profit, 1 week ago
Money Today, 2 weeks ago
International Business Times India, 1 week ago
Pharma Letter


The Competition Commission of India (CCI) last week approved the merger of Ranbaxy Laboratories with Sun Pharma on the condition that 7 overlapping products of the two companies should be sold out in six months to avoid a monopoly situation in the ...
 PharmaBiz2 days ago Sensex ends 71 pts down, Nifty below 8050; ITC falls 3%  Money Control2 days ago Ranbaxy may establish production in Russia  Pharma Letter3 days ago Deal clincher: Sun hoists its flag on domestic pharma landscape  Financial Express5 days ago

Thomson Reuters Analysis Identifies Hi-Tech Engineering and Pharma Companies as Front Runners of Innovation in India

The Intellectual Property & Science business of T homson Reuters , the world's leading source of intelligent information for businesses and professionals, announced the launch of its 2014 State of Innovation India report today. This is the second ...
 Bobsguide3 days ago Thomson Reuters identifies pharma companies & hi-tech engineering as front runners of innovation in India  PharmaBiz4 days ago Thomson Reuters Analysis declares 2nd India Innovation Awards  India Infoline1 week ago
Financial Express

BSE Sensex, NSE Nifty fall for 5th straight session; auto, FMCG, pharma stocks hit

Indian shares edged lower as volatility in global markets raised fears of foreign selling, although indexes cut early losses. (Reuters) Extending its fall for the fifth straight session, the benchmark BSE Sensex closed down by 71 points at ...
 Financial Express2 days ago Nifty ends below 8,050; ITC, Sun Pharma dip 2%  Business Standard2 days ago Nifty seeing support at 8,300; ITC, Sun Pharma up 3%  Business Standard1 month ago Markets trading flat; Sun Pharma, Hero Moto top losers  Business Standard1 month ago
Business Standard

Nifty struggles at 8200, Sensex drags; Cipla, GAIL weak

HDFC is still up 4 percent while Coal India, ONGC, Hero MotoCorp and Sun Pharma are top gainers in the Sensex. TCS, Sesa Sterlite, Cipla, GAIL and Infosys are among the laggards.
 Money Control4 days ago BSE Sensex, Nifty flat; Tata Power ONGC jump 2%  Money Control1 week ago Markets remain flat; Tata Power, Sesa Sterlite up 2%  Business Standard1 week ago Sensex, Nifty flat; ITC declines, Tata Power rises  Money Control3 weeks ago
NDTV Profit

Sensex, Nifty sluggish; Reliance, ONGC, Tata Steel fall 2%

BHEL, Dr Reddy's Labs, MM, HDFC and Sun Pharma are top gainers while Reliance, ONGC, Tata Steel, Infosys and GAIL are major laggards.
 Money Control1 week ago Sensex, Nifty Edge Lower; Sun Pharma, Ranbaxy Gain  NDTV Profit1 week ago Sun Pharma, Ranbaxy, OnMobile Global in Focus Today  NDTV Profit1 week ago Sensex, Nifty under pressure; banks, tech, cap goods drag  Moneycontrol.com1 week ago
Business Standard India

Pharma shares under pressure; CNX Pharma index down nearly 4%

Wockhardt, Glenmark, Torrent Pharma,Aurobindo Pharma, Lupin, Strides Arcolab and Biocon were down 5-9%. SI Reporter | Mumbai December 17, 2014 Last Updated at 10:25 IST Shares of pharmaceutical companies are under pressure, falling by up to 9% on ...
 Business Standard India3 days ago Select pharma shares rally on heavy volumes  Business Standard India2 weeks ago SPARC rises on USFDA response to drug application  Money Today2 weeks ago SPARC spurts after USFDA issues complete response letter to new drug application  Business Standard2 weeks ago

Buy Infosys, Sun Pharma: Ambareesh Baliga

Ambareesh Baliga, Independent Market Expert is of the view that one may buy Infosys, HCL Technologies and Sun Pharmaceutical Industries.
 Money Control2 days ago Expecting markets to go down further: Ambareesh Baliga  Economic Times3 days ago

Trading Strategies for Glenmark, Dr Reddys Lab, Sun Pharma, Lupin, Divis Lab

S&P CNX NIFTY CMP 8029.80 Near Term: Techncal bounce could be expected on charts whereas resistance on charts is expected around 8100.00 Best trading strategy for traders would be buy on dips. Related Stories No Related Stories Found ...
 Smart Investor2 days ago

Pharma exporters slump; EM currency rout hurts

Reuters Market Eye - Pharmaceutical stocks slump - Glenmark Pharmaceutical (GLEN.NS) falls 6 pct, Aurobindo Pharma (ARBN.NS) slumps 6.8 pct, Lupin (LUPN.NS) loses 5.3 pct. Ranbaxy Laboratories (RANB.NS) down 4 pct, Cipla (CIPL.NS) loses 3.6 pct, Sun ...
 Yahoo! Finance3 days ago Lupin, Glenmark Pharma Slump; EM Currency Rout Hurts  NDTV Profit3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma
Get updated on latest news & your favorite topics right in your inbox!
More     Less